Wendy L. Yarno's most recent trade in Ideaya Biosciences Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ideaya Biosciences Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Iovance Biotherapeutics Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 67,546 | 67,546 | - | - | Deferred Restricted Stock Unit | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 4,540 | 4,540 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 13,700 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2025 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 2,954 | 2,954 | - | - | Restricted Stock Units | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 10,512 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 2,167 | 0 | - | - | Restricted Stock Unit | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2024 | 3,350 | 10,350 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Iovance Biotherapeutics Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 49,303 | 49,303 | - | - | Deferred Restricted Stock Unit | |
| Ideaya Biosciences Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,917 | 2,917 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 2,167 | 2,167 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,166 | 8,345 (0%) | 0% | - | Common Stock | |
| Iovance Biotherapeutics Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 25,000 | 25,000 | - | - | Deferred Restricted Stock Unit | |
| Tarsus Pharmaceuticals Inc | Yarno L. Wendy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 5,000 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | L. Wendy Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 5,000 | 7,000 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 3,350 | 3,350 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 0 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 2,000 | 2,000 | - | - | Common Stock | |
| Ideaya Biosciences Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| Iovance Biotherapeutics Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 12,988 | 12,988 | - | - | Deferred Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 35,000 | 35,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 26,000 | 26,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 19,000 | 74,153 (0%) | 0% | - | Common Stock | |
| Iovance Biotherapeutics Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2023 | 74,823 | 74,823 | - | - | Deferred Restricted Stock Unit | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 2,000 | 2,000 | - | - | Restricted Stock Units | |
| Ideaya Biosciences Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 28,000 | 28,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 19,000 | 19,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 55,153 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 18,000 | 0 | - | - | Restricted Stock Unit | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 27,000 | 27,000 | - | - | Common Stock Options | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 18,000 | 18,000 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 8,700 | 37,153 (0%) | 0% | - | Common Stock | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2020 | 4,090 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharmaceuticals Inc | Wendy L. Yarno | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2020 | 4,090 | 28,453 (0%) | 0% | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Wendy L. Yarno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |